FOSAMPRENAVIR

UNII:	WOU1621EEG
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₃₆N₃O₉PS
Preferred Substance Name:	FOSAMPRENAVIR
InChIKey:	MLBVMOWEQCZNCC-OEMFJLHTSA-N
GSRS Full Record:	WOU1621EEG i

226700-79-4
(3S)-TETRAHYDRO-3-FURYL ((.ALPHA.S)-.ALPHA.-((1R)-1-HYDROXY-2-(N1-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE PHOSPHATE (ESTER)
CARBAMIC ACID, ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2-(PHOSPHONOOXY)PROPYL)-, C-(3S)-TETRAHYDRO-3-FURANYL) ESTER
FOSAMPRENAVIR [HSDB]
FOSAMPRENAVIR [MI]
FOSAMPRENAVIR [VANDF]
Fosamprenavir [WHO-DD]
GW-433908
GW433908
GW433908A
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate
fosamprenavir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

FOSAMPRENAVIR

Synonyms and Mappings

Resources